Surgery Partners Inc. said its board authorized a share buyback program under which it may repurchase up to $50 million of its common stock.
Surgery Partners board approves $50M share buyback
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Surgery Partners board approves $50M share buyback
- Author Ravikash Bakolia
- Theme Healthcare & Pharmaceuticals
- Author
- Ravikash Bakolia
- Theme
- Healthcare & Pharmaceuticals
